(Q39860040)

English

KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer

scientific article published on April 2009

Statements

KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer (English)
1 reference
Jen Jen Yeh
1 reference
Elizabeth D Routh
1 reference
Tara Rubinas
1 reference
Janie Peacock
1 reference
Timothy D Martin
1 reference
Xiang Jun Shen
1 reference
Hong Jin Kim
1 reference
Temitope O Keku
1 reference
Channing J Der
1 reference
1 April 2009
1 reference
8
1 reference
834-843
1 reference
4
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit